BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 20093508)

  • 21. Parotid gland tumors: can addition of diffusion-weighted MR imaging to dynamic contrast-enhanced MR imaging improve diagnostic accuracy in characterization?
    Yabuuchi H; Matsuo Y; Kamitani T; Setoguchi T; Okafuji T; Soeda H; Sakai S; Hatakenaka M; Nakashima T; Oda Y; Honda H
    Radiology; 2008 Dec; 249(3):909-16. PubMed ID: 18941162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal cell carcinoma: diffusion-weighted MR imaging for subtype differentiation at 3.0 T.
    Wang H; Cheng L; Zhang X; Wang D; Guo A; Gao Y; Ye H
    Radiology; 2010 Oct; 257(1):135-43. PubMed ID: 20713607
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Accuracy of MRI in the detection of residual breast cancer after neoadjuvant chemotherapy.
    Rosen EL; Blackwell KL; Baker JA; Soo MS; Bentley RC; Yu D; Samulski TV; Dewhirst MW
    AJR Am J Roentgenol; 2003 Nov; 181(5):1275-82. PubMed ID: 14573420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rectal cancer: assessment of complete response to preoperative combined radiation therapy with chemotherapy--conventional MR volumetry versus diffusion-weighted MR imaging.
    Curvo-Semedo L; Lambregts DM; Maas M; Thywissen T; Mehsen RT; Lammering G; Beets GL; Caseiro-Alves F; Beets-Tan RG
    Radiology; 2011 Sep; 260(3):734-43. PubMed ID: 21673229
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-small cell lung cancer: detection of early response to chemotherapy by using contrast-enhanced dynamic and diffusion-weighted MR imaging.
    Yabuuchi H; Hatakenaka M; Takayama K; Matsuo Y; Sunami S; Kamitani T; Jinnouchi M; Sakai S; Nakanishi Y; Honda H
    Radiology; 2011 Nov; 261(2):598-604. PubMed ID: 21852569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of depth of myometrial invasion and overall staging in endometrial cancer: comparison of diffusion-weighted and dynamic contrast-enhanced MR imaging.
    Beddy P; Moyle P; Kataoka M; Yamamoto AK; Joubert I; Lomas D; Crawford R; Sala E
    Radiology; 2012 Feb; 262(2):530-7. PubMed ID: 22114239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and radiologic assessments to predict breast cancer pathologic complete response to neoadjuvant chemotherapy.
    Schott AF; Roubidoux MA; Helvie MA; Hayes DF; Kleer CG; Newman LA; Pierce LJ; Griffith KA; Murray S; Hunt KA; Paramagul C; Baker LH
    Breast Cancer Res Treat; 2005 Aug; 92(3):231-8. PubMed ID: 16155794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Meta-analysis of magnetic resonance imaging in detecting residual breast cancer after neoadjuvant therapy.
    Marinovich ML; Houssami N; Macaskill P; Sardanelli F; Irwig L; Mamounas EP; von Minckwitz G; Brennan ME; Ciatto S
    J Natl Cancer Inst; 2013 Mar; 105(5):321-33. PubMed ID: 23297042
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contrast-enhanced MR mammography for evaluation of the contralateral breast in patients with diagnosed unilateral breast cancer or high-risk lesions.
    Pediconi F; Catalano C; Roselli A; Padula S; Altomari F; Moriconi E; Pronio AM; Kirchin MA; Passariello R
    Radiology; 2007 Jun; 243(3):670-80. PubMed ID: 17446524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neoadjuvant Systemic Therapy in Breast Cancer: Association of Contrast-enhanced MR Imaging Findings, Diffusion-weighted Imaging Findings, and Tumor Subtype with Tumor Response.
    Santamaría G; Bargalló X; Fernández PL; Farrús B; Caparrós X; Velasco M
    Radiology; 2017 Jun; 283(3):663-672. PubMed ID: 27875106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Accuracy of clinical examination, digital mammogram, ultrasound, and MRI in determining postneoadjuvant pathologic tumor response in operable breast cancer patients.
    Croshaw R; Shapiro-Wright H; Svensson E; Erb K; Julian T
    Ann Surg Oncol; 2011 Oct; 18(11):3160-3. PubMed ID: 21947594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Readout-segmented echo-planar imaging improves the diagnostic performance of diffusion-weighted MR breast examinations at 3.0 T.
    Bogner W; Pinker-Domenig K; Bickel H; Chmelik M; Weber M; Helbich TH; Trattnig S; Gruber S
    Radiology; 2012 Apr; 263(1):64-76. PubMed ID: 22438442
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diffusion-weighted MR for differentiation of breast lesions at 3.0 T: how does selection of diffusion protocols affect diagnosis?
    Bogner W; Gruber S; Pinker K; Grabner G; Stadlbauer A; Weber M; Moser E; Helbich TH; Trattnig S
    Radiology; 2009 Nov; 253(2):341-51. PubMed ID: 19703869
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diffusion-weighted imaging improves the diagnostic accuracy of conventional 3.0-T breast MR imaging.
    Ei Khouli RH; Jacobs MA; Mezban SD; Huang P; Kamel IR; Macura KJ; Bluemke DA
    Radiology; 2010 Jul; 256(1):64-73. PubMed ID: 20574085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MR imaging for assessment of breast cancer response to neoadjuvant chemotherapy.
    Hylton N
    Magn Reson Imaging Clin N Am; 2006 Aug; 14(3):383-9, vii. PubMed ID: 17098179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination of 18F-FDG PET/CT and diffusion-weighted MR imaging as a predictor of histologic response to neoadjuvant chemotherapy: preliminary results in osteosarcoma.
    Byun BH; Kong CB; Lim I; Choi CW; Song WS; Cho WH; Jeon DG; Koh JS; Lee SY; Lim SM
    J Nucl Med; 2013 Jul; 54(7):1053-9. PubMed ID: 23670899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-small cell lung cancer: whole-body MR examination for M-stage assessment--utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/CT.
    Ohno Y; Koyama H; Onishi Y; Takenaka D; Nogami M; Yoshikawa T; Matsumoto S; Kotani Y; Sugimura K
    Radiology; 2008 Aug; 248(2):643-54. PubMed ID: 18539889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Preoperative evaluation of pathologic response in patients with breast cancer by dynamic contrast-enhanced magnetic resonance imaging].
    Zhang XP; Li J; Sun YS; Cao K; Tang L
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Feb; 30(1):98-103. PubMed ID: 18361063
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction of clinicopathologic response of breast cancer to primary chemotherapy at contrast-enhanced MR imaging: initial clinical results.
    Padhani AR; Hayes C; Assersohn L; Powles T; Makris A; Suckling J; Leach MO; Husband JE
    Radiology; 2006 May; 239(2):361-74. PubMed ID: 16543585
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Locally advanced rectal carcinoma treated with preoperative chemotherapy and radiation therapy: preliminary analysis of diffusion-weighted MR imaging for early detection of tumor histopathologic downstaging.
    Sun YS; Zhang XP; Tang L; Ji JF; Gu J; Cai Y; Zhang XY
    Radiology; 2010 Jan; 254(1):170-8. PubMed ID: 20019139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.